In acknowledging Greater Than One (GTO) as a premiere healthcare agency of 2021, Medical Marketing and Media (MM+M) recognized that our unique integration of data, content, media, and technology makes us truly greater than the sum of our parts.
Greater Than One (GTO) has been recognized by PM360 for its success in conceiving and launching a virtual campaign to support OXLUMO® (lumasiran), a first-in-class therapy developed by Alnylam.
Chief Executive Officer and Honeycomb Health (HH) co-founder Elizabeth Apelles discusses why the high-tech nonprofit will forever change the lives of rare disease patients everywhere, and shares the buzz about her co-founder’s road trip to raise $3M dollars.
Explore the GTO POV on how leading with digital health solutions like wearables, social advocacy, and remote monitoring can make a world of difference in diagnosing and treating rare diseases.
